calcipotriene NDC 16714-763

NDC codes

FDA NDC Directory

Product NDC (as listed)16714-763Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16714-0763Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16714-763-01	16714076301	1 TUBE in 1 CARTON (16714-763-01) / 60 g in 1 TUBEMarketed from May 1, 2018
16714-763-02	16714076302	1 TUBE in 1 CARTON (16714-763-02) / 120 g in 1 TUBEMarketed from May 1, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): calcipotriene
Generic name (nonproprietary): calcipotriene
Active ingredients: Calcipotriene — 50 ug/g
Dosage form: Cream
Route: Topical
Labeler: Northstar Rx LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205772
Marketing start: Jun 1, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Vitamin D (Chemical structure)
Identifiers: Product ID 16714-763_ee33f5da-8d1a-429e-aa0c-15d19353fc44SPL ID ee33f5da-8d1a-429e-aa0c-15d19353fc44SPL set ID a882ef4f-603e-4421-97ae-2c78822c767aRxCUI 313921UNII 143NQ3779BUPC 0316714763019
Pharmacologic class: Vitamin D Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416714076301 followed by a unit qualifier and the quantity

Package 16714-0763-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 24, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Calcipotriene cream, 0.005%, is indicated for the treatment of plaque psoriasis. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205772

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205772
Product	Strength	Form · route	Labeler	Product NDC
calcipotriene	Calcipotriene 50 ug/g	CreamTopical	Glenmark Pharmaceuticals Inc.,USA	68462-501